Mad Street Den Announces New Appointments to its Advisory Board
Mad Street Den's Founder,
General
"We are honored to have this group of veterans in the industry advising us as we continue on this journey," said
About Mad Street Den
Mad Street Den is an award-winning enterprise AI company transforming businesses across the globe. Its proprietary AI stack, Blox is the world's first general-purpose AI platform that powers applications across workflows delivering value, unlike any other point solution. With a combination of ready-to-use APIs, no-code, and low-code tools, Blox enables marketing, product and technology teams to bring an order of magnitude improvement to lead generation, churn reduction, revenue growth, cost efficiency, and more. Blox is currently deployed across several industries, including Retail (under the brand name Vue.ai), healthcare, finance, media and entertainment, education, and more.
Mad Street Den is backed by leading investors such as
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), relating to future events or the future financial performance of the Company. Such forward-looking statements are only predictions or statements of intention subject to risks and uncertainties and actual events or results could differ materially from those anticipated. Because actual results may differ, shareholders and prospective investors are cautioned not to place undue reliance on such forward-looking statements.
View original content:https://www.prnewswire.com/news-releases/mad-street-den-announces-new-appointments-to-its-advisory-board-301782064.html
SOURCE Mad Street Den
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AVCON DELIVERS KING AIR B200 MOSQUITO CONTROL AIRCRAFT MODIFICATION
- TEN Holdings Announces Key Dates for 2026 Annual Meeting of Stockholders
- Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Sequoia Capital, AdComSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share